Biotech Acquisition Company

Biotech Acquisition Company

BIOTW
Biotech Acquisition CompanyUS flagNASDAQ Capital Market
0.01
USD
- -
- -
Biotech Acquisition Company
BIOTW
(NASDAQ Capital Market)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Biotech Acquisition Company operates as a special purpose acquisition company. Established in September 2020, the firm maintains its headquarters in New York, New York. Its core mission involves pursuing a business combination, such as a merger or acquisition, primarily targeting opportunities within the healthcare and biotechnology sectors.